Alim Hirji

Associate Professor, Faculty of Medicine & Dentistry - Medicine Dept

Contact Overview Publications

Contact

Associate Professor, Faculty of Medicine & Dentistry - Medicine Dept

Email: ahirji@ualberta.ca

Overview

Area of Study / Keywords

Lung Transplant PFT Weight CLAD Transplant Lung Organ Allocation LAS

About

Dr. Alim Hirji is currently appointed as Associate Professor in the Department of Medicine in the Faculty of Medicine & Dentistry.

Featured Publications

Corrigendum: "Pre-transplant malignancy is associated with increased risk of de novo malignancy post-lung transplantation"

Sekowski V., Jackson K., Halloran K., Varughese R., Nagendran J., Weinkauf J., Lien D., Hirji A.

RESPIRATORY MEDICINE. 2022 August; 200 10.1016/j.rmed.2022.106914

Mismatched perfusion defects on routine ventilation-perfusion scans after lung transplantation

Li D., Abele J., Sunner P., Varughese R., Hirji A., Weinkauf J., Nagendran J., Lien D., Halloran K.

CLINICAL TRANSPLANTATION. 2022 June; 36 (6) 10.1111/ctr.14650

Pre-transplant malignancy is associated with increased risk of de novo malignancy post-lung transplantation

Sekowski V., Jackson K., Halloran K., Varughese R., Nagendran J., Weinkauf J., Lien D., Hirji A.

RESPIRATORY MEDICINE. 2022 June; 197 10.1016/j.rmed.2022.106855

Top Molecules Associated With CLAD In Lung Transplants Are Shared Between Mucosal Biopsies, Transbronchial Biopsies, And Kidney Transplant Biopsies At Risk Of Progression

American Transplant Congress. 2022 June;

Acute Lung Injury in Interstitial Lung Disease Is Not Associated Post-Transplant Survival

ISHLT. 2022 April; 10.1016/j.healun.2022.01.1358

Pre-transplant medications and primary graft dysfunction risk in lung transplant recipients

ISHLT. 2022 April; 10.1016/j.healun.2022.01.720

Prognostic value of first post-transplant lung function

ISHLT. 2022 April; 10.1016/j.healun.2022.01.1341

Transcripts associated with chronic lung allograft dysfunction in transbronchial biopsies of lung transplants

Parkes M.D., Halloran K., Hirji A., Pon S., Weinkauf J., Timofte I.L., Snell G.I., Westall G.P., Havlin J., Lischke R., Zajacová A., Hachem R., Kreisel D., Levine D., Kubisa B., Piotrowska M., Juvet S., Keshavjee S., Jaksch P., Klepetko W., Halloran P.F.

AMERICAN JOURNAL OF TRANSPLANTATION. 2022 April; 22 (4):1054-1072 10.1111/ajt.16895

Bilateral Lung Transplant for Treatment of Idiopathic Pulmonary Fibrosis With Undetected Lung Adenocarcinoma: A Case Report

Jogiat U.M., Chu Q.S., Nagendran J., Laing B., Hirji A., Adam B.A.

ANTICANCER RESEARCH. 2022 February; 42 (2):1157-1160 10.21873/anticanres.15580

Lung Transplantation from Donors with a History of Substance Use

ISHLT. 2022 January; 10.1016/j.healun.2022.01.1621

Baseline lung allograft dysfunction in primary graft dysfunction survivors after lung transplantation

Li D., Weinkauf J., Kapasi A., Hirji A., Varughese R., Lien D., Nagendran J., Halloran K.

RESPIRATORY MEDICINE. 2021 November; 188 10.1016/j.rmed.2021.106617

Successful Long-Term Outcome After Transplantation of Lungs Affected by Smoke Inhalation Injury

Moolji J., Gill I., Varughese R., Adam B., Halloran K., Weinkauf J., Lien D., Mullen J., Hirji A.

ANNALS OF THORACIC SURGERY. 2021 October; 114 (1):e25-e28 10.1016/j.athoracsur.2021.09.045

Progressive Dyspnea With Recurrent Pneumothoraces

Homer K.L., Mandziuk J., Hirji A., Barrie J., Meyer S.R., Wong E.Y.L., Puttagunta L., Halloran K.M.

CHEST. 2021 August; 160 (2):e209-e215 10.1016/j.chest.2021.03.052

Atelectasis in primary graft dysfunction survivors after lung transplantation

Li D., Abele J., Weinkauf J., Kapasi A., Hirji A., Varughese R., Nagendran J., Lien D., Doucette K., Halloran K.

CLINICAL TRANSPLANTATION. 2021 July; 35 (7) 10.1111/ctr.14315

Assessing the efficacy and safety of hydroxychloroquine as outpatient treatment of COVID-19: a randomized controlled trial

Ilan Schwartz 1, Mari E Boesen 1, Graziela Cerchiaro 1, Craig Doram 1, Brett D Edwards 1, Aravind Ganesh 1, Jamie Greenfield 1, Scott Jamieson 1, Vikram Karnik 1, Carol Kenney 1, Rachel Lim 1, Bijoy K Menon 1, Kwadwo Mponponsuo 1, Sarah Rathwell 1, Karla J Ryckborst 1, Breanne Stewart 1, Maryna Yaskina 1, Luanne Metz 1, Lawrence Richer 1, Michael D Hill 2, ALBERTA HOPE COVID-19 Collaborators

CMAJ Open. 2021 June; 9 (2):E693-E702 10.9778/cmajo.20210069

Atelectasis in primary graft dysfunction survivors after lung transplantation

Li D., Abele J., Weinkauf J., Kapasi A., Hirji A., Varughese R., Nagendran J., Lien D., Doucette K., Halloran K.

CLINICAL TRANSPLANTATION. 2021 April; 35 (7) 10.1111/ctr.14315

Diagnostic yield and impact of bronchoscopy in patients with a hematological malignancy or hematopoietic stem cell transplant presenting with pulmonary complications.

ATS. 2021 April; Am J Respir Crit Care Med 2021;203:A3860

High immunologic risk lung transplantation using risk stratified induction

ISHLT. 2021 April;

Hospitalization status at time of lung transplant for interstitial lung disease does not affect post transplant outcomes

ISHLT. 2021 April; https://doi.org/10.1016/j.healun.2021.01.1026

Prognostic implications of abnormal left-right lung perfusion differential on routine post-transplant ventilation-perfusion scans

ISHLT. 2021 April;

Prognostic Significance of Asymptomatic Pulmonary Embolism on Routine Ventilation-Perfusion Scans after Lung Transplantation

ISHLT. 2021 April;

Rare Case of Neutrophilic Dermatosis in Lung Transplant Recipient

ISHLT. 2021 April;

Systemic Corticosteroids and Lung Function Recovery after Respiratory Viral Infection in Lung Transplant Recipients

ISHLT. 2021 April; 10.1016/j.healun.2021.01.957

Torque Teno Virus as a Predictor of Cytomegalovirus Infection Post-Lung Transplantation

ISHLT. 2021 April;

Chest X-ray Sizing for Lung Transplants Reflects Pulmonary Diagnosis and Body Composition and Is Associated with Primary Graft Dysfunction Risk

Li D., Weinkauf J., Hirji A., Nagendran J., Kapasi A., Lien D., Halloran K.

TRANSPLANTATION. 2021 February; 105 (2):382-389 10.1097/TP.0000000000003238

Azithromycin prophylaxis after lung transplantation is associated with improved overall survival

Li D., Duan Q., Weinkauf J., Kapasi A., Varughese R., Hirji A., Lien D., Meyer S., Laing B., Nagendran J., Halloran K.

JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2020 December; 39 (12):1426-1434 10.1016/j.healun.2020.09.006

Molecular T-cell?mediated rejection in transbronchial and mucosal lung transplant biopsies is associated with future risk of graft loss

Halloran K., Parkes M.D., Timofte I., Snell G., Westall G., Havlin J., Lischke R., Hachem R., Kreisel D., Levine D., Kubisa B., Piotrowska M., Juvet S., Keshavjee S., Jaksch P., Klepetko W., Hirji A., Weinkauf J., Halloran P.F.

JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2020 December; 39 (12):1327-1337 10.1016/j.healun.2020.08.013

Clinical transplantation using negative pressure ventilation ex situ lung perfusion with extended criteria donor lungs

Buchko M.T., Boroumand N., Cheng J.C., Hirji A., Halloran K., Freed D.H., Nagendran J.

Nature Communications. 2020 November; 11 (1) 10.1038/s41467-020-19581-4